Skip to main content

Advertisement

Log in

Interventions to Address Chronic Disease and HIV: Strategies to Promote Smoking Cessation Among HIV-infected Individuals

  • Behavioral Aspects of HIV Management (RJ DiClemente and JL Brown, Section Editors)
  • Published:
Current HIV/AIDS Reports Aims and scope Submit manuscript

Abstract

Tobacco use, especially cigarette smoking, is higher than average in persons living with HIV/AIDS (PLWHA). The Public Health Service Clinical Practice Guideline for Treating Tobacco Use and Dependence states that, during every medical encounter, all smokers should be offered smoking cessation counseling, along with approved medications. The Guideline also recognizes PLWHA as a priority population, given the scarcity of research on effective cessation treatments in this group. The scant evidence suggests that conventional treatments, though worthwhile, are not as successful as might be hoped for. The reasons for this are not entirely clear, but may have to do with the complex array of medical and psychosocial factors that complicate their lives. Clinicians should consider re-treatment strategies for those patients who encounter difficulty when quitting smoking with conventional approaches, switching or augmenting treatments as needed to minimize adverse experiences, and to maximize tolerability, adherence, and cessation outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291:1238.

    Article  PubMed  Google Scholar 

  2. Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res. 2005;7:511–22.

    Article  PubMed  Google Scholar 

  3. Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav. 2010;14:824–35.

    Article  PubMed  Google Scholar 

  4. Niaura R, Shadel WG, Morrow K, Tashima K, Flanigan T, Abrams DB. Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis. 2000;31:808–12.

    Article  PubMed  CAS  Google Scholar 

  5. Benard A, Bonnet F, Tessier JF, Fossoux H, Dupon M, Mercie P, et al. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine cohort. AIDS Patient Care STDS. 2007;21:458–68.

    Article  PubMed  Google Scholar 

  6. Lloyd-Richardson EE, Stanton CA, Papandonatos GD, Betancourt RM, Stein M, Tashima K, et al. HIV-positive smokers considering quitting: differences by race/ethnicity. Am J Health Behav. 2008;32:3.

    Article  PubMed  Google Scholar 

  7. Rahmanian S, Wewers ME, Koletar S, Reynolds N, Ferketich A, Diaz P. Cigarette smoking in the HIV-infected population. Proc Am Thorac Soc. 2011;8:313–9.

    Article  PubMed  Google Scholar 

  8. Gritz ER, Vidrine DJ, Lazev AB, Amick BCI, Arduino RC. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res. 2004;6:71–7.

    Article  PubMed  Google Scholar 

  9. • Lifson AR, Lando HA. Smoking and HIV: prevalence, health risks, and cessation strategies. Curr HIV/AIDS Rep. 2012;9(3):223–30. A comprehensive review of the health consequences of smoking in HIV-infected patients.

  10. Kohli R, Lo Y, Homel P, Flanigan TP, Gardner LI, Howard AA, et al. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clin Infect Dis. 2006;43(1):90–8.

    Article  PubMed  Google Scholar 

  11. Patel N, Talwar A, Reichert VC, Brady T, Jain M, Kaplan MH. Tobacco and HIV. Clin Occup Environ Med. 2006;5:193.

    PubMed  Google Scholar 

  12. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004;164:2206.

    Article  PubMed  Google Scholar 

  13. Crothers K, Butt AA, Gibert CL, Rodriguez-Barradas MC, Crystal S, Justice AC, Veterans Aging Cohort 5 Project Team. Increased COPD among HIV-positive compared with HIV-negative veterans. Chest. 2006;130:1326–33.

    Article  PubMed  Google Scholar 

  14. Crothers K, Griffith TA, McGinnis KA, Rodriguez-Barradas MC, Leaf DA, Weissman S, et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med. 2005;20:1142–5.

    Article  PubMed  Google Scholar 

  15. Crothers K, Tindle HA. Prevention of bacterial pneumonia in HIV infection: focus on smoking cessation. Expert Rev Anti Infect Ther. 2011;9:759–62.

    Article  PubMed  Google Scholar 

  16. Cockerham L, Scherzer R, Zolopa A, Rimland D, Lewis CE, Bacchetti P, et al. Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era. J Acquir Immune Defic Syndr. 2010;53:102–6.

    Article  PubMed  Google Scholar 

  17. Lifson AR, Neuhaus J, Arribas JR, van den Berg-Wolf M, Labriola AM, Read TR. Smoking-related health risks among persons with HIV in the strategies for management of antiretroviral therapy clinical trial. Am J Public Health. 2010;100(10):1896–903.

    Google Scholar 

  18. Petoumenos K, Worm S, Reiss P, de Wit S, d'Arminio Monforte A, Sabin C, et al. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study. HIV Med. 2011;12(7):412–21.

    Google Scholar 

  19. Piper ME, Kenford S, Fiore MC, Baker TB. Smoking cessation and quality of life: changes in life satisfaction over 3 years following a quit attempt. Ann Behav Med. 2011;43(2):262–70.

    Google Scholar 

  20. Vidrine DJ, Arduino RC, Gritz ER. The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/AIDS. AIDS Patient Care STDS. 2007;21:659–66.

    Article  PubMed  Google Scholar 

  21. Flicker L. Modifiable lifestyle risk factors for Alzheimer’s disease. J Alzheimers Dis. 2010;20:803–11.

    PubMed  Google Scholar 

  22. Lasser K, Boyd J, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA. 2000;284:2606.

    Article  PubMed  CAS  Google Scholar 

  23. Ziedonis D, Hitsman B, Beckham JC, Zvolensky M, Adler LE, Audrain-McGovern J, et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health Report. Nicotine Tob Res. 2008;10:1691–715.

    Article  PubMed  Google Scholar 

  24. McClave AK, McKnight-Eily LR, Davis SP, Dube SR. Smoking characteristics of adults with selected lifetime mental illnesses: results from the 2007 National Health Interview Survey. Am J Public Health. 2010;100:2464–72.

    Article  PubMed  Google Scholar 

  25. Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts H, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the Women's Interagency HIV Study. Am J Public Health. 2006;96:1060–5.

    Article  PubMed  Google Scholar 

  26. Shuter J, Bernstein SL. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine Tob Res. 2008;10:731–6.

    Article  PubMed  CAS  Google Scholar 

  27. Marks King R, Vidrine DJ, Danysh HE, Fletcher FE, McCurdy S, Arduino RC, et al. Factors associated with nonadherence to antiretroviral therapy in HIV-positive smokers. AIDS Patient Care STDS. 2012;26(8):479–85.

    Google Scholar 

  28. Reynolds NR. Cigarette smoking and HIV: more evidence for action. AIDS Educ Prev. 2009;21(3 Suppl):106–21.

    Article  PubMed  Google Scholar 

  29. Humfleet GL, Delucchi K, Kelley K, Hall SM, Dilley J, Harrison G. Characteristics of HIV-positive cigarette smokers: a sample of smokers facing multiple challenges. AIDS Educ Prev. 2009;21 Suppl 3:54–64.

    Article  PubMed  Google Scholar 

  30. Cargill VA, Stone VE. HIV/AIDS: a minority health issue. Med Clin North Am. 2005;89:895–912.

    Article  PubMed  Google Scholar 

  31. Cox LS, Okuyemi K, Choi WS, Ahluwalia JS. A review of tobacco use treatments in U.S. ethnic minority populations. Am J Health Promot. 2011;25(5 Suppl):S11–30.

    PubMed  Google Scholar 

  32. Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service Report. Am J Prev Med. 2008;35:158–76.

  33. Elzi L, Spoerl D, Voggensperger J, Nicca D, Simcock M, Bucher HC, et al. A smoking cessation program in HIV-infected individuals: a pilot study. Antivir Ther. 2006;11:787–95.

    PubMed  Google Scholar 

  34. Ingersoll KS, Cropsey KL, Heckman CJ. A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS Behav. 2009;13:545–54.

    Article  PubMed  Google Scholar 

  35. Vidrine DJ, Marks RM, Arduino RC, Gritz ER. Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine Tob Res. 2011;14:106–10.

    Article  PubMed  Google Scholar 

  36. Moadel AB, Bernstein SL, Mermelstein RJ, Arnsten JH, Dolce EH, Shuter J. A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. J Acquir Immune Defic Syndr. 2012. doi:10.1097/QAI.0b013e3182645679.

  37. Lloyd-Richardson EE, Stanton CA, Papandonatos GD, Shadel WG, Stein M, Tashima K, et al. Motivation and patch treatment for HIV + smokers: a randomized controlled trial. Addiction. 2009;104:1891–900.

    Article  PubMed  Google Scholar 

  38. Stanton CA, Lloyd-Richardson EE, Papandonatos GD, de Dios MA, Niaura R. Mediators of the relationship between nicotine replacement therapy and smoking abstinence among people living with HIV/AIDS. AIDS Educ Prev. 2009;21(3 Suppl):65–80.

    Article  PubMed  Google Scholar 

  39. Pedrol-Clotet E, Deig-Comerma E, Ribell-Bachs M, Vidal-Castell I, García-Rodríguez P. Soler A [Bupropion use for smoking cessation in hiv-infected patients receiving antiretroviral therapy]. Enferm Infecc Microbiol Clin. 2006;24:509–11.

    Article  PubMed  Google Scholar 

  40. Tornero C, Mafé C. Varenicline and antiretroviral therapy in patients with HIV. J Acquir Immune Defic Syndr. 2009;52:656.

    PubMed  Google Scholar 

  41. Cui Q, Robinson L, Elston D, Smaill F, Cohen J, Quan C, et al. Safety and tolerability of varenicline tartrate (champix(®)/chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study. AIDS Patient Care STDS. 2011;26(1):12–19.

    Google Scholar 

  42. Shuter J, Salmo LN, Shuter AD, Nivasch EC, Fazzari M, Moadel AB. Provider beliefs and practices relating to tobacco use in patients living with HIV/AIDS: a national survey. AIDS Behav. 2011;16(2):288–94.

    Google Scholar 

  43. Kirshenbaum AP, Olsen DM, Bickel WK. A quantitative review of the ubiquitous relapse curve. J Subst Abuse Treat. 2009;36:8–17.

    Article  PubMed  Google Scholar 

  44. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99:29–38.

    Article  PubMed  Google Scholar 

  45. Hughes JR, Peters EN, Naud S. Relapse to smoking after 1 year of abstinence: a meta-analysis. Addict Behav. 2008;33:1516–20.

    Article  PubMed  Google Scholar 

  46. Huber M, Ledergerber B, Jaccard R, Elzi L, Furrer H, Hirschel B, et al. Smoking prevalence, cessation rates and relapse rates in the Swiss HIV cohort study (SHCS). J Int AIDS Soc. 2010;13:1–2.

    Article  Google Scholar 

  47. Hajek P, Stead LF, West R, Jarvis M, Lancaster T. Relapse prevention interventions for smoking cessation. Status and date: new search for studies and content updated (conclusions changed), Published in 2009. Cochrane Database Syst Rev. 2009;21(1):CD003999.

    Google Scholar 

  48. • Agboola S, McNeill A, Coleman T, Leonardi Bee J. A systematic review of the effectiveness of smoking relapse prevention interventions for abstinent smokers. Addiction. 2010;105:1362–80. A comprehensive review of behavioral and pharmacologic smoking relapse prevention treatments, along with meta-analyses.

    Article  PubMed  Google Scholar 

  49. Killen JD, Fortmann SP, Newman B, Varady A. Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol. 1990;58:85–92.

    Article  PubMed  CAS  Google Scholar 

  50. Fortmann SP, Killen JD. Nicotine gum and self-help behavioral treatment for smoking relapse prevention: results from a trial using population-based recruitment. J Consult Clin Psychol. 1995;63:460–8.

    Article  PubMed  CAS  Google Scholar 

  51. Croghan IT, Hurt RD, Dakhil SR, Croghan GA, Sloan JA, Novotny PJ, et al. Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention. Mayo Clin Proc. 2007;82:186–95.

    PubMed  CAS  Google Scholar 

  52. Covey LS, Glassman AH, Jiang H, Fried J, Masmela J, LoDuca C, et al. A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse. Addiction. 2007;102:1292–302.

    Article  PubMed  Google Scholar 

  53. Hays JT, Hurt RD, Rigotti NA, Niaura R, Gonzales D, Durcan MJ, et al. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. A randomized, controlled trial. Ann Intern Med. 2001;135:423–33.

    PubMed  CAS  Google Scholar 

  54. Hurt RD, Krook JE, Croghan IT, Loprinzi CL, Sloan JA, Novotny PJ, et al. Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking. J Clin Oncol. 2003;21:914.

    Article  PubMed  CAS  Google Scholar 

  55. Killen JD, Fortmann SP, Murphy GM, Hayward C, Arredondo C, Cromp D, et al. Extended treatment with bupropion SR for cigarette smoking cessation. J Consult Clin Psychol. 2006;74:286–94.

    Article  PubMed  Google Scholar 

  56. Tonstad S, Tønnesen P, Hajek P, Williams KE, Billing CB, Reeves KR, Varenicline Phase 3 Study Group. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA. 2006;296:64–71.

    Article  PubMed  CAS  Google Scholar 

  57. Joseph AM, Rice K, An LC, Mohiuddin A, Lando H. Recent quitters' interest in recycling and harm reduction. Nicotine Tob Res. 2004;6:1075.

    Article  PubMed  Google Scholar 

  58. Fu SS, Partin MR, Snyder A, An LC, Nelson DB, Clothier B, et al. Promoting repeat tobacco dependence treatment: are relapsed smokers interested? Am J Manag Care. 2006;12:235–43.

    PubMed  Google Scholar 

  59. Cupertino AP, Wick JA, Richter KP, Mussulman L, Nazir N, Ellerbeck EF. The impact of repeated cycles of pharmacotherapy on smoking cessation: a longitudinal cohort study. Arch Intern Med. 2009;169:1928–30.

    Article  PubMed  Google Scholar 

  60. Hughes J. An algorithm for choosing among smoking cessation treatments. J Subst Abuse Treat. 2008;34:426–32.

    Article  PubMed  Google Scholar 

  61. Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz N, Curry SJ, et al. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Executive Summary. Rockville MD: US Department of Health and Human Services. Public Health Service. May 2008.

  62. Niaura R, Abrams DB. Smoking cessation: progress, priorities, and prospectus. J Consult Clin Psychol. 2002;70:494.

    Article  PubMed  Google Scholar 

  63. Abrams DB, Orleans CT, Niaura RS, Goldstein MG, Prochaska JO, Velicer W. Integrating individual and public health perspectives for treatment of tobacco dependence under managed health care: a combined stepped-care and matching model. Ann Behav Med. 1996;18:290–304.

    Article  PubMed  CAS  Google Scholar 

  64. Sobell MB, Sobell LC. Stepped care as a heuristic approach to the treatment of alcohol problems. J Consult Clin Psychol. 2000;68:573.

    Article  PubMed  CAS  Google Scholar 

  65. Breslin FC, Sobell MB, Sobell LC, Cunningham JA, Sdao-Jarvie K, Borsoi D. Problem drinkers: evaluation of a stepped-care approach. J Subst Abuse. 1998;10:217–32.

    Article  PubMed  CAS  Google Scholar 

  66. Murphy SA, Lynch KG, Oslin D, McKay JR, TenHave T. Developing adaptive treatment strategies in substance abuse research. Drug Alcohol Depend. 2007;88 Suppl 2:S24–30.

    Article  PubMed  Google Scholar 

  67. Hughes JR, Grass JA, Pillitteri JL. Treatment resistant smokers: a pilot study of nicotine nasal spray and inhaler. J Addict Dis. 2000;19:95–100.

    Article  PubMed  CAS  Google Scholar 

  68. Tønnesen P, Nørregaard J, Säwe U, Simonsen K. Recycling with nicotine patches in smoking cessation. Addiction. 1993;88:533–9.

    Article  PubMed  Google Scholar 

  69. Tonnesen P, Mikkelsen K, Norregaard J, Jorgensen S. Recycling of hard-core smokers with nicotine nasal spray. Eur Respir J. 1996;9:1619.

    Article  PubMed  CAS  Google Scholar 

  70. Gourlay SG, Forbes A, Marriner T, Pethica D, McNeil JJ. Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers. BMJ. 1995;311:363–6.

    Article  PubMed  CAS  Google Scholar 

  71. Smith SS, Jorenby DE, Fiore MC, Anderson JE, Mielke MM, Beach KE, et al. Strike while the iron is hot: can stepped-care treatments resurrect relapsing smokers? J Consult Clin Psychol. 2001;69:429.

    Article  PubMed  CAS  Google Scholar 

  72. Gonzalez DH, Nides M, Ferry LH, Segall N, Herrero LA, Krishen A, et al. Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study. Clin Pharmacol Ther. 2001;69:438–44.

    Article  Google Scholar 

  73. Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis S, Whicher D, Schwartz JS. Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Intern Med. 2009;151:206.

    PubMed  Google Scholar 

  74. Lavori PW, Dawson R. Adaptive treatment strategies in chronic disease. Annu Rev Med. 2008;59:443–53.

    Article  PubMed  CAS  Google Scholar 

  75. Steinberg MB, Schmelzer AC, Richardson DL, Foulds J. The case for treating tobacco dependence as a chronic disease. Ann Intern Med. 2008;148:554–6.

    PubMed  Google Scholar 

  76. Joseph AM, Fu SS, Lindgren B, Rothman AJ, Kodl M, Lando H, et al. Chronic disease management for tobacco dependence: a randomized, controlled trial. Arch Intern Med. 2011;171:1894–900.

    Article  PubMed  Google Scholar 

  77. Chakraborty B. Dynamic treatment regimes for managing chronic health conditions: a statistical perspective. Am J Public Health. 2011;101:40–5.

    Article  PubMed  Google Scholar 

  78. Lavori PW, Dawson R. Dynamic treatment regimes: practical design considerations. Clin Trials. 2004;1:9.

    Article  PubMed  Google Scholar 

  79. Chakraborty B, Murphy S, Strecher V. Inference for non-regular parameters in optimal dynamic treatment regimes. Stat Methods Med Res. 2010;19:317–43.

    Article  PubMed  Google Scholar 

  80. Murphy SA, Van Der Laan MJ, Robins JM. Marginal mean models for dynamic regimes. J Am Stat Assoc. 2001;96:1410–23.

    Article  PubMed  Google Scholar 

  81. Murphy SA. An experimental design for the development of adaptive treatment strategies. Stat Med. 2005;24:1455–81.

    Article  PubMed  CAS  Google Scholar 

  82. • Lei H, Nahum-Shani I, Lynch K, Oslin D, Murphy SA. A "SMART" design for building individualized treatment sequences. Annu Rev Clin Psychol. 2012;8:21–48. A good review of how to conceive of, construct, and test adaptive treatment strategies.

    Article  PubMed  CAS  Google Scholar 

  83. Pineau J, Bellemare MG, Rush AJ, Ghizaru A, Murphy SA. Constructing evidence-based treatment strategies using methods from computer science. Drug Alcohol Depend. 2007;88 Suppl 2:S52–60.

    Article  PubMed  Google Scholar 

  84. Thall PF, Logothetis C, Pagliaro LC, Wen S, Brown MA, Williams D, et al. Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of 4 regimens. J Natl Cancer Inst. 2007;99:1613–22.

    Article  PubMed  CAS  Google Scholar 

  85. Collins LM, Murphy SA, Strecher V. The multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART): new methods for more potent health interventions. Am J Prev Med. 2007;32(5 Suppl):S112–8.

    Article  PubMed  Google Scholar 

  86. Dawson R, Green AI, Drake RE, McGlashan TH, Schanzer B, Lavori PW. Developing and testing adaptive treatment strategies using substance-induced psychosis as an example. Psychopharmacol Bull. 2008;41:51–67.

    PubMed  Google Scholar 

  87. Buyze J, Van Rompaye B, Goetghebeur E. Designing a sequentially randomized study with adherence enhancing interventions for diabetes patients. Stat Med. 2010;29:1114–26.

    PubMed  Google Scholar 

  88. Brown CH, Ten Have TR, Jo B, Dagne G, Wyman PA, Muthén B, et al. Adaptive designs for randomized trials in public health. Annu Rev Public Health. 2009;30:1–25.

    Article  PubMed  Google Scholar 

  89. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2011;2:CD006103.

    Google Scholar 

  90. Hughes J, Stead L, Lancaster T, Rev CDS. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2007;1:CD000031.

    Google Scholar 

  91. Carrozzi L, Pistelli F, Viegi G. Pharmacotherapy for smoking cessation. Ther Adv Respir Dis. 2008;2:301–17.

    Article  PubMed  Google Scholar 

  92. Faessel HM, Obach RS, Rollema H, Ravva P, Williams KE, Burstein AH. A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation. Clin Pharmacokinet. 2010;49:799–816.

    Article  PubMed  CAS  Google Scholar 

  93. Ebbert JO, Croghan IT, Sood A, Schroeder DR, Hays JT, Hurt RD. Varenicline and bupropion sustained-release combination therapy for smoking cessation. Nicotine Tob Res. 2009;11:234–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Raymond Niaura.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Niaura, R., Chander, G., Hutton, H. et al. Interventions to Address Chronic Disease and HIV: Strategies to Promote Smoking Cessation Among HIV-infected Individuals. Curr HIV/AIDS Rep 9, 375–384 (2012). https://doi.org/10.1007/s11904-012-0138-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11904-012-0138-4

Keywords

Navigation